Nicola Personeni

24PUBLICATIONS
122CO-AUTHORS
Liquid biopsiesGene and molecular therapyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Oct 18, 2025
Inter-hospital heterogeneity in the authorizations of off-label cancer drugs: A project by Associazione Italiana di Oncologia Medica.

Anna Amela Valsecchi, Matilde Scaldaferri, Marcello Tiseo

|Nov 27, 2024
A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for MGMT Gene Promoter Hypermethylation Detection.

Marco Macagno, Valeria Pessei, Noemi Congiusta

|Dec 11, 2022
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.

Yue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D'Alessio

|Oct 27, 2022
Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment.

Nicola Personeni, Tiziana Pressiani, Valentina Zanuso

|Sep 21, 2022
Assessment and Monitoring of Response to Systemic Treatment in Advanced Hepatocellular Carcinoma: Current Insights.

Antonella Cammarota, Valentina Zanuso, Tiziana Pressiani

|Aug 26, 2022
Multidisciplinary Tumor Board in the Management of Patients with Colorectal Liver Metastases: A Single-Center Review of 847 Patients.

Flavio Milana, Simone Famularo, Antonio Luberto

Pageof 4

Frequent Collaborators

18 joint publications

Lorenza Rimassa

11 joint publications

Antonio D'Alessio

8 joint publications

Antonella Cammarota

5 joint publications

Valentina Zanuso